Viewing Study NCT01129206

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 1:16 PM
Ignite Modification Date: 2026-03-03 @ 4:48 PM
Study NCT ID: NCT01129206
Status: COMPLETED
Last Update Posted: 2016-06-01
First Post: 2010-05-21
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy
Sponsor: Ohio State University Comprehensive Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adenocarcinoma of the Esophagus View
None Adenocarcinomas of the Gastroesophageal Junction View
None Recurrent Esophageal Cancer View
None Squamous Cell Carcinoma of the Esophagus View
None Stage IV Esophageal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Gastroesophageal Cancer View
None Gastroesophageal Carcinoma View
None Adenocarcinoma View